Hepatitis C, innate immunity and alcohol: Friends or foes?

Biomolecules

Volumn 5, Issue 1, 2015, Pages 76-94

  Osna, Natalia A ^a,b   Ganesan, Murali ^a,b   Kharbanda, Kusum K ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; Ethanol; HCV; HCV RNA; Hepatocytes; Innate immunity; Interferon signaling; Toll like receptors

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYCLIN G1; CYTOCHROME P450 2E1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; JANUS KINASE; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; MICRORNA 122; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NONSTRUCTURAL PROTEIN 3; PEPTIDES AND PROTEINS; RETINOIC ACID INDUCIBLE PROTEIN I; SOFOSBUVIR; STAT1 PROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; ALCOHOL;

ADAPTIVE IMMUNITY; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; APOPTOSIS; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); FATTY ACID OXIDATION; HEPATITIS C; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIPID PEROXIDATION; LIVER CELL; MUTATION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; CYTOLOGY; DRUG EFFECTS; HEPACIVIRUS; IMMUNOLOGY; LIVER; METABOLISM; PATHOGENICITY; VIROLOGY;

HEPATITIS C VIRUS;

ETHANOL; HEPACIVIRUS; HUMANS; IMMUNITY, INNATE; LIVER; VIRUS REPLICATION;

EID: 84943173851     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5010076     Document Type: Review

References (110)

1. Ye, L.; Wang, S.; Wang, X.; Zhou, Y.; Li, J.; Persidsky, Y.; Ho, W. Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes. Drug Alcohol Depend. 2010, 112, 107-116.
2. Jamal, M. M.; Morgan, T. R. Liver disease in alcohol and hepatitis C. Best Pract. Res. Clin. Gastroenterol. 2003, 17, 649-662.
3. Szabo, G.; Aloman, C.; Polyak, S. J.; Weinman, S. A.; Wands, J.; Zakhari, S. Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcohol. Clin. Exp. Res. 2006, 30, 709-719.
4. Khan, K. N.; Yatsuhashi, H. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients. Alcohol Alcohol. 2000, 35, 286-295.
5. Poynard, T.; Bedossa, P.; Opolon, P.; The Obsvirc, Metavir, Clinivir, and Dosvirc Groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997, 349, 825-832.
6. Okazaki, T.; Yoshihara, H.; Suzuki, K.; Yamada, Y.; Tsujimura, T.; Kawano, K.; Abe, H. Efficacy of interferon therapy in patients with chronic hepatitis C: Comparison between non-drinkers and drinkers. Scand. J. Gastroenterol. 1994, 29, 1039-1043.
7. Lieber, C. S. Hepatitis C and alcohol. J. Clin. Gastroenterol. 2003, 36, 100-102.
8. Otani, K.; Korenaga, M.; Beard, M. R.; Li, K.; Qian, T.; Showalter, L. A.; Singh, A. K.; Wang, T.; Weinman, S. A. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005, 128, 96-107.
9. Deng, L.; Shoji, I.; Ogawa, W.; Kaneda, S.; Soga, T.; Jiang, D. P.; Ide, Y. H.; Hotta, H. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J. Virol. 2011, 85, 8556-8568.
10. Machida, K.; Cheng, K. T.; Lai, C. K.; Jeng, K. S.; Sung, V. M.; Lai, M. M. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J. Virol. 2006, 80, 7199-7207.
11. Osna, N. A.; White, R. L.; Krutik, V. M.; Wang, T.; Weinman, S. A.; Donohue, T. M., Jr. Proteasome activation by hepatitis C core protein is reversed by ethanol-induced oxidative stress. Gastroenterology 2008, 134, 2144-2152.
12. Siu, L.; Foont, J.; Wands, J. R. Hepatitis C virus and alcohol. Semin. Liver Dis. 2009, 29, 188-199.
13. Singal, A. K.; Anand, B. S. Mechanisms of synergy between alcohol and hepatitis C virus. J. Clin. Gastroenterol. 2007, 41, 761-772.
14. Sherman, K. E.; Rouster, S. D.; Mendenhall, C.; Thee, D. Hepatitis crna quasispecies complexity in patients with alcoholic liver disease. Hepatology 1999, 30, 265-270.
15. Takahashi, K.; Takahashi, T.; Takahashi, S.; Watanabe, K.; Boku, S.; Matsui, S.; Arai, F.; Asakura, H. Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients. J. Gastroenterol. Hepatol. 2001, 16, 416-423.
16. Seronello, S.; Montanez, J.; Presleigh, K.; Barlow, M.; Park, S. B.; Choi, J. Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals. PLOS ONE 2011, 6, e27436.
17. McCartney, E. M.; Semendric, L.; Helbig, K. J.; Hinze, S.; Jones, B.; Weinman, S. A.; Beard, M. R. Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. J. Infect. Dis. 2008, 198, 1766-1775.
18. Seronello, S.; Ito, C.; Wakita, T.; Choi, J. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J. Biol. Chem. 2010, 285, 845-854.
19. Seronello, S.; Sheikh, M. Y.; Choi, J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic. Biol. Med. 2007, 43, 869-882.
20. Elaut, G.; Henkens, T.; Papeleu, P.; Snykers, S.; Vinken, M.; Vanhaecke, T.; Rogiers, V. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug Metab. 2006, 7, 629-660.
21. Hou, W.; Bukong, T. N.; Kodys, K.; Szabo, G. Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells. Alcohol. Clin. Exp. Res. 2013, 37, 599-608.
22. Bukong, T. N.; Hou, W.; Kodys, K.; Szabo, G. Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells. Hepatology 2013, 57, 70-80.
23. Randall, G.; Panis, M.; Cooper, J. D.; Tellinghuisen, T. L.; Sukhodolets, K. E.; Pfeffer, S.; Landthaler, M.; Landgraf, P.; Kan, S.; Lindenbach, B. D.; et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. USA 2007, 104, 12884-12889.
24. Neuman, M. G.; French, S. W.; French, B. A.; Seitz, H. K.; Cohen, L. B.; Mueller, S.; Osna, N. A.; Kharbanda, K. K.; Seth, D.; Bautista, A.; et al. Alcoholic and non-alcoholic steatohepatitis. Exp. Mol. Pathol. 2014, 97, 492-510.
25. Osna, N. A.; Kharbanda, K. K.; Sun, Y.; Simpson, R. L.; Poluektova, L. E.; Ganesan, M.; Wisecarver, J. L.; Mercer, D. F. Ethanol affects hepatitis C pathogenesis: Humanized SCID Alb-upA mouse model. Biochem. Biophys. Res. Commun. 2014, 450, 773-776.
26. Bhattacharya, R.; Shuhart, M. C. Hepatitis C and alcohol: Interactions, outcomes, and implications. J. Clin. Gastroenterol. 2003, 36, 242-252.
27. Pessione, F.; Degos, F.; Marcellin, P.; Duchatelle, V.; Njapoum, C.; Martinot-Peignoux, M.; Degott, C.; Valla, D.; Erlinger, S.; Rueff, B. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998, 27, 1717-1722.
28. Anand, B. S.; Thornby, J. Alcohol has no effect on hepatitis C virus replication: A meta-analysis. Gut 2005, 54, 1468-1472.
29. Bartenschlager, R.; Pietschmann, T. Efficient hepatitis C virus cell culture system: What a difference the host cell makes. Proc. Natl. Acad. Sci. USA 2005, 102, 9739-9740.
30. Seth, R. B.; Sun, L.; Ea, C. K.; Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-+B and IRF 3. Cell 2005, 122, 669-682.
31. Horner, S. M.; Liu, H. M.; Park, H. S.; Briley, J.; Gale, M., Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. USA 2011, 108, 14590-14595.
32. Li, K.; Lemon, S. M. Innate immune responses in hepatitis C virus infection. Semin. Immunopathol. 2013, 35, 53-72.
33. Funami, K.; Matsumoto, M.; Oshiumi, H.; Akazawa, T.; Yamamoto, A.; Seya, T. The cytoplasmic "linker region" in toll-like receptor 3 controls receptor localization and signaling. Int. Immunol. 2004, 16, 1143-1154.
34. Kawai, T.; Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 2008, 1143, 1-20.
35. Colonna, M. TLR pathways and IFN-regulatory factors: To each its own. Eur. J. Immunol. 2007, 37, 306-309.
36. Hornung, V.; Guenthner-Biller, M.; Bourquin, C.; Ablasser, A.; Schlee, M.; Uematsu, S.; Noronha, A.; Manoharan, M.; Akira, S.; de Fougerolles, A.; et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005, 11, 263-270.
37. Szabo, G.; Dolganiuc, A.; Mandrekar, P. Pattern recognition receptors: A contemporary view on liver diseases. Hepatology 2006, 44, 287-298.
38. Szabo, G.; Dolganiuc, A. Hepatitis C and innate immunity: Recent advances. Clin. Liver Dis. 2008, 12, 675-692.
39. Liu, Y. J. Ipc: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23, 275-306.
40. Qashqari, H.; Al-Mars, A.; Chaudhary, A.; Abuzenadah, A.; Damanhouri, G.; Alqahtani, M.; Mahmoud, M.; El Sayed Zaki, M.; Fatima, K.; Qadri, I. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance. Infect. Genet. Evol. 2013, 19, 113-119.
41. Sarasin-Filipowicz, M.; Oakeley, E. J.; Duong, F. H.; Christen, V.; Terracciano, L.; Filipowicz, W.; Heim, M. H. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. USA 2008, 105, 7034-7039.
42. Sato, K.; Ishikawa, T.; Okumura, A.; Yamauchi, T.; Sato, S.; Ayada, M.; Matsumoto, E.; Hotta, N.; Oohashi, T.; Fukuzawa, Y.; et al. Expression of toll-like receptors in chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 2007, 22, 1627-1632.
43. Li, K.; Foy, E.; Ferreon, J. C.; Nakamura, M.; Ferreon, A. C.; Ikeda, M.; Ray, S. C.; Gale, M., Jr.; Lemon, S. M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 2005, 102, 2992-2997.
44. Gale, M., Jr.; Foy, E. M. Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436, 939-945.
45. Imran, M.; Waheed, Y.; Manzoor, S.; Bilal, M.; Ashraf, W.; Ali, M.; Ashraf, M. Interaction of hepatitis C virus proteins with pattern recognition receptors. Virol. J. 2012, doi: 10. 1186/1743-422X-9-126.
46. Moriyama, M.; Kato, N.; Otsuka, M.; Shao, R. X.; Taniguchi, H.; Kawabe, T.; Omata, M. Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, AND NS5A. Hepatol. Int. 2007, 1, 302-310.
47. Chang, S.; Kodys, K.; Szabo, G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 2010, 51, 35-42.
48. Yakushijin, T.; Kanto, T.; Inoue, M.; Oze, T.; Miyazaki, M.; Itose, I.; Miyatake, H.; Sakakibara, M.; Kuzushita, N.; Hiramatsu, N.; et al. Reduced expression and functional impairment of toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection. Hepatol. Res. 2006, 34, 156-162.
49. Szabo, G.; Dolganiuc, A. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 2005, 210, 237-247.
50. Dolganiuc, A.; Chang, S.; Kodys, K.; Mandrekar, P.; Bakis, G.; Cormier, M.; Szabo, G. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 2006, 177, 6758-6768.
51. Hoffmann, M.; Zeisel, M. B.; Jilg, N.; Paranhos-Baccala, G.; Stoll-Keller, F.; Wakita, T.; Hafkemeyer, P.; Blum, H. E.; Barth, H.; Henneke, P.; et al. Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles. J. Innate Immun. 2009, 1, 446-454.
52. Chang, S.; Dolganiuc, A.; Szabo, G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 2007, 82, 479-487.
53. Shiina, M.; Rehermann, B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 2008, 47, 385-395.
54. Stone, A. E.; Mitchell, A.; Brownell, J.; Miklin, D. J.; Golden-Mason, L.; Polyak, S. J.; Gale, M. J., Jr.; Rosen, H. R. Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. PLOS ONE 2014, 9, e95627.
55. Broering, R.; Wu, J.; Meng, Z.; Hilgard, P.; Lu, M.; Trippler, M.; Szczeponek, A.; Gerken, G.; Schlaak, J. F. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J. Hepatol. 2008, 48, 914-922.
56. Hosomura, N.; Kono, H.; Tsuchiya, M.; Ishii, K.; Ogiku, M.; Matsuda, M.; Fujii, H. HCV-related proteins activate kupffer cells isolated from human liver tissues. Dig. Dis. Sci. 2011, 56, 1057-1064.
57. Negash, A. A.; Ramos, H. J.; Crochet, N.; Lau, D. T.; Doehle, B.; Papic, N.; Delker, D. A.; Jo, J.; Bertoletti, A.; Hagedorn, C. H.; et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLOS Pathog. 2013, 9, e1003330.
58. Fletcher, N. F.; Sutaria, R.; Jo, J.; Barnes, A.; Blahova, M.; Meredith, L. W.; Cosset, F. L.; Curbishley, S. M.; Adams, D. H.; Bertoletti, A.; et al. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology 2014, 59, 1320-1330.
59. Oshiumi, H.; Funami, K.; Aly, H. H.; Matsumoto, M.; Seya, T. Multi-step regulation of interferon induction by hepatitis C virus. Arch. Immunol. Ther. Exp. 2013, 61, 127-138.
60. Park, S. J.; Hahn, Y. S. Regulation of host innate immunity by hepatitis C virus: Crosstalk between hepatocyte and NK/DC. Rev. Infect. 2010, 1, 151-157.
61. Rosen, H. R. Emerging concepts in immunity to hepatitis C virus infection. J. Clin. Investig. 2013, 123, 4121-4130.
62. Tamura, R.; Kanda, T.; Imazeki, F.; Wu, S.; Nakamoto, S.; Tanaka, T.; Arai, M.; Fujiwara, K.; Saito, K.; Roger, T.; et al. Hepatitis C virus nonstructural 5A protein inhibits lipopolysaccharidemediated apoptosis of hepatocytes by decreasing expression of toll-like receptor 4. J. Infect. Dis. 2011, 204, 793-801.
63. Leung, S.; Qureshi, S. A.; Kerr, I. M.; Darnell, J. E., Jr.; Stark, G. R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 1995, 15, 1312-1317.
64. Gupta, S.; Yan, H.; Wong, L. H.; Ralph, S.; Krolewski, J.; Schindler, C. The SH2 domains of STAT1 and STAT2 mediate multiple interactions in the transduction of IFN-alpha signals. EMBO J. 1996, 15, 1075-1084.
65. Ramana, C. V.; Chatterjee-Kishore, M.; Nguyen, H.; Stark, G. R. Complex roles of STAT1 in regulating gene expression. Oncogene 2000, 19, 2619-2627.
66. Kramer, O. H.; Knauer, S. K.; Greiner, G.; Jandt, E.; Reichardt, S.; Guhrs, K. H.; Stauber, R. H.; Bohmer, F. D.; Heinzel, T. A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev. 2009, 23, 223-235.
67. Borden, E. C.; Sen, G. C.; Uze, G.; Silverman, R. H.; Ransohoff, R. M.; Foster, G. R.; Stark, G. R. Interferons at age 50: Past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007, 6, 975-990.
68. Balagopal, A.; Thomas, D. L.; Thio, C. L. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010, 139, 1865-1876.
69. Lin, W.; Kim, S. S.; Yeung, E.; Kamegaya, Y.; Blackard, J. T.; Kim, K. A.; Holtzman, M. J.; Chung, R. T. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 2006, 80, 9226-9235.
70. Stevenson, N. J.; Bourke, N. M.; Ryan, E. J.; Binder, M.; Fanning, L.; Johnston, J. A.; Hegarty, J. E.; Long, A.; O'Farrelly, C. Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett. 2013, 587, 1571-1578.
71. Kumthip, K.; Chusri, P.; Jilg, N.; Zhao, L.; Fusco, D. N.; Zhao, H.; Goto, K.; Cheng, D.; Schaefer, E. A.; Zhang, L.; et al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J. Virol. 2012, 86, 8581-8591.
72. Bode, J. G.; Ludwig, S.; Ehrhardt, C.; Albrecht, U.; Erhardt, A.; Schaper, F.; Heinrich, P. C.; Haussinger, D. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 2003, 17, 488-490.
73. Duong, F. H.; Christen, V.; Filipowicz, M.; Heim, M. H. S-adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro. Hepatology 2006, 43, 796-806.
74. Duong, F. H.; Christen, V.; Lin, S.; Heim, M. H. Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology 2010, 51, 741-751.
75. Duong, F. H.; Filipowicz, M.; Tripodi, M.; la Monica, N.; Heim, M. H. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004, 126, 263-277.
76. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434, 772-777.
77. Ma, C. J.; Ni, L.; Zhang, Y.; Zhang, C. L.; Wu, X. Y.; Atia, A. N.; Thayer, P.; Moorman, J. P.; Yao, Z. Q. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology 2011, 132, 421-431.
78. Taylor, D. R.; Shi, S. T.; Romano, P. R.; Barber, G. N.; Lai, M. M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999, 285, 107-110.
79. Gale, M. J., Jr.; Korth, M. J.; Tang, N. M.; Tan, S. L.; Hopkins, D. A.; Dever, T. E.; Polyak, S. J.; Gretch, D. R.; Katze, M. G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997, 230, 217-227.
80. Dabo, S.; Meurs, E. F. DsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses 2012, 4, 2598-2635.
81. Castanier, C.; Zemirli, N.; Portier, A.; Garcin, D.; Bidere, N.; Vazquez, A.; Arnoult, D. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol. 2012, doi: 10. 1186/1741-7007-10-44.
82. Jia, Y.; Song, T.; Wei, C.; Ni, C.; Zheng, Z.; Xu, Q.; Ma, H.; Li, L.; Zhang, Y.; He, X.; et al. Negative regulation of MAVS-mediated innate immune response by PSMA7. J. Immunol. 2009, 183, 4241-4248.
83. Arnaud, N.; Dabo, S.; Akazawa, D.; Fukasawa, M.; Shinkai-Ouchi, F.; Hugon, J.; Wakita, T.; Meurs, E. F. Hepatitis C virus reveals a novel early control in acute immune response. PLOS Pathog. 2011, 7, e1002289.
84. Heim, M. H. Innate immunity and HCV. J. Hepatol. 2013, 58, 564-574.
85. Heintges, T.; Wands, J. R. Hepatitis C virus: Epidemiology and transmission. Hepatology 1997, 26, 521-526.
86. Petrasek, J.; Dolganiuc, A.; Csak, T.; Nath, B.; Hritz, I.; Kodys, K.; Catalano, D.; Kurt-Jones, E.; Mandrekar, P.; Szabo, G. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 2011, 53, 649-660.
87. Pruett, S. B.; Schwab, C.; Zheng, Q.; Fan, R. Suppression of innate immunity by acute ethanol administration: A global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J. Immunol. 2004, 173, 2715-2724.
88. Pruett, S. B.; Zheng, Q.; Fan, R.; Matthews, K.; Schwab, C. Acute exposure to ethanol affects toll-like receptor signaling and subsequent responses: An overview of recent studies. Alcohol 2004, 33, 235-239.
89. Byun, J. S.; Suh, Y. G.; Yi, H. S.; Lee, Y. S.; Jeong, W. I. Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating kupffer cells and stellate cells to produce interleukin-10 in mice. J. Hepatol. 2013, 58, 342-349.
90. Pang, M.; Bala, S.; Kodys, K.; Catalano, D.; Szabo, G. Inhibition of TLR8-and TLR4-induced type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes. BMC Immunol. 2011, doi: 10. 1186/1471-2172-12-55.
91. Testro, A. G.; Visvanathan, K. Toll-like receptors and their role in gastrointestinal disease. J. Gastroenterol. Hepatol. 2009, 24, 943-954.
92. Mandrekar, P.; Bala, S.; Catalano, D.; Kodys, K.; Szabo, G. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J. Immunol. 2009, 183, 1320-1327.
93. Machida, K. TLRs, alcohol, HCV, and tumorigenesis. Gastroenterol. Res. Pract. 2010, doi: 10. 1155/2010/518674.
94. Mueller, S.; Millonig, G.; Seitz, H. K. Alcoholic liver disease and hepatitis C: A frequently underestimated combination. World J. Gastroenterol. 2009, 15, 3462-3471.
95. Machida, K.; Tsukamoto, H.; Mkrtchyan, H.; Duan, L.; Dynnyk, A.; Liu, H. M.; Asahina, K.; Govindarajan, S.; Ray, R.; Ou, J. H.; et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc. Natl. Acad. Sci. USA 2009, 106, 1548-1553.
96. Moriya, K.; Fujie, H.; Shintani, Y.; Yotsuyanagi, H.; Tsutsumi, T.; Ishibashi, K.; Matsuura, Y.; Kimura, S.; Miyamura, T.; Koike, K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4, 1065-1067.
97. Ceni, E.; Mello, T.; Galli, A. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J. Gastroenterol. 2014, 20, 17756-17772.
98. Plumlee, C. R.; Lazaro, C. A.; Fausto, N.; Polyak, S. J. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol. J. 2005, doi: 10. 1186/1743-422X-2-89.
99. Nguyen, V. A.; Chen, J.; Hong, F.; Ishac, E. J.; Gao, B. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: Differential regulation by acute ethanol via a protein kinase C-dependent mechanism. Biochem. J. 2000, 349, 427-434.
100. Osna, N. A.; Clemens, D. L.; Donohue, T. M., Jr. Ethanol metabolism alters interferon gamma signaling in recombinant HEPG2 cells. Hepatology 2005, 42, 1109-1117.
101. Osna, N. A.; Donohue, T. M., Jr. CYP2E1-catalyzed alcohol metabolism: Role of oxidant generation in interferon signaling, antigen presentation and autophagy. Subcell. Biochem. 2013, 67, 177-197.
102. Bala, S.; Petrasek, J.; Mundkur, S.; Catalano, D.; Levin, I.; Ward, J.; Alao, H.; Kodys, K.; Szabo, G. Circulating micrornas in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56, 1946-1957.
103. Li, J.; Liu, K.; Liu, Y.; Xu, Y.; Zhang, F.; Yang, H.; Liu, J.; Pan, T.; Chen, J.; Wu, M.; et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat. Immunol. 2013, 14, 793-803.
104. Encke, J.; Wands, J. R. Ethanol inhibition: The humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization. Alcohol. Clin. Exp. Res. 2000, 24, 1063-1069.
105. Encke, J.; zu Putlitz, J.; Geissler, M.; Wands, J. R. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 1998, 161, 4917-4923.
106. Donohue, T. M., Jr.; Osna, N. A.; Trambly, C. S.; Whitaker, N. P.; Thomes, P. G.; Todero, S. L.; Davis, J. S. Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcohol. Clin. Exp. Res. 2012, 36, 759-767.
107. Osna, N. A.; White, R. L.; Thiele, G. M.; Donohue, T. M., Jr. Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cells. Hepatology 2009, 49, 1308-1315.
108. Osna, N. A.; White, R. L.; Todero, S.; McVicker, B. L.; Thiele, G. M.; Clemens, D. L.; Tuma, D. J.; Donohue, T. M., Jr. Ethanol-induced oxidative stress suppresses generation of peptides for antigen presentation by hepatoma cells. Hepatology 2007, 45, 53-61.
109. Osna, N.; McVicker, B.; Poluektova, L.; Ganesan, M.; Kharbanda, K. Mode of oral ethanol feeding affects liver oxidative stress levels and methylation status: Study on NS5A-transgenic mice. Int. J. Biochem. Res. Rev. 2014, 4, 344-357.
110. Donaldson, E. F.; Harrington, P. R.; O'Rear, J. J.; Naeger, L. K. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatology 2015, 61, 56-65.